LPA and metabolic syndrome: Elevated serum levels of Lp(a), or hyperlipoproteinemia (a), represent a notable component of dyslipidemia due to Lp(a)’s high atherogenicity index, as there is substantial evidence [2,3,4] clearly indicating that Lp(a) is an independent atherogenic factor.